MyOme
Empowering individuals to take control of their health through actionable genomic insights.
About MyOme
MyOme uses whole-genome sequencing and state-of-the-art bioinformatics to analyze patient DNA and produce comprehensive and clinically actionable reports that allow patients and their providers to make personalized lifestyle, prevention, and treatment choices. The company offers proactive and diagnostic tests that can be ordered by healthcare providers, including services for screening, medication response, and rare disease diagnosis.
Industry
Biotechnology / Genomic Testing / Precision Medicine
Headquarters
Menlo Park, California, United States
Company size
51-200
Founded
2017
What we do
Whole-genome sequencingGenomic risk predictionPolygenic risk scoresPrecision medicineProactive health testingRare disease diagnosticsClinical genomic analysis
Interested in MyOme?
Join our talent pool to be considered for future opportunities.